The Role of Glomerular and Serum Expression of Lymphocyte Activating Factors BAFF and APRIL in Patient with Membranous and IgA Nephropathies
Authors
Barbara Moszczuk
Department of Clinical Immunology, Medical University of Warsaw, Warsaw, Poland
Department of Transplantology, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
ProMix Center (ProteogenOmix in Medicine), Department of Clinical Immunology, Medical University of Warsaw, Warsaw, Poland
Krzysztof Mucha
Department of Transplantology, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
ProMix Center (ProteogenOmix in Medicine), Department of Clinical Immunology, Medical University of Warsaw, Warsaw, Poland
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
Róża Kucharczyk
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
Radosław Zagożdżon
ProMix Center (ProteogenOmix in Medicine), Department of Clinical Immunology, Medical University of Warsaw, Warsaw, Poland
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
Laboratory of Cellular and Genetic Therapies, Center for Preclinical Research, Medical University of Warsaw, Warsaw, Poland
DOI: https://doi.org/10.2478/aite-2025-0018 | Journal eISSN: 1661-4917
Language: English
Submitted on: Dec 31, 2024
Accepted on: Apr 15, 2025
Published on: Jun 5, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2025 Barbara Moszczuk, Krzysztof Mucha, Róża Kucharczyk, Radosław Zagożdżon, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.